Valion Bio, Inc. financial statements
Valion Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 382K | EODHD |
| Net income | −USD 8.88M | 10-K |
| Cash and equivalents | USD 12.64M | 10-Q |
| Total debt | USD 6.45M | EODHD |
Valion Bio, Inc. financials on 6ix · Valion Bio, Inc. on 6ix